Citadel Advisors
AMPE

Citadel Advisors’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Citadel Advisors’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-382
Closed -$1.78K – 15783
2023
Q1 		$1.78K Buy
382
+215
+129% +$1.21K ﹤0.01% 14249
2022
Q4 		$752 Buy
+167
New +$1.08K ﹤0.01% 14589
2022
Q3 		– Sell
-2,210
Closed -$77.4K – 14146
2022
Q2 		$111K Buy
2,210
+2,137
+2,927% +$159K ﹤0.01% 11316
2022
Q1 		$10K Sell
73
-490
-87% -$71.6K ﹤0.01% 13382
2021
Q4 		$96K Buy
563
+361
+179% +$135K ﹤0.01% 12763
2021
Q3 		$100K Buy
202
+24
+13% +$11.1K ﹤0.01% 12873
2021
Q2 		$89K Sell
178
-1,233
-87% -$662K ﹤0.01% 13014
2021
Q1 		$716K Buy
1,411
+1,057
+299% +$545K ﹤0.01% 8893
2020
Q4 		$169K Buy
354
+155
+78% +$50.8K ﹤0.01% 9866
2020
Q3 		$57K Buy
199
+84
+73% +$20.8K ﹤0.01% 9553
2020
Q2 		$22K Sell
115
-517
-82% -$86K ﹤0.01% 9538
2020
Q1 		$79K Buy
632
+473
+297% +$85.6K ﹤0.01% 8795
2019
Q4 		$28K Sell
159
-57
-26% -$7.36K ﹤0.01% 8888
2019
Q3 		$32K Hold
216
– – ﹤0.01% 8835
2019
Q2 		$25K Buy
216
+124
+135% +$19.6K ﹤0.01% 8910
2019
Q1 		$15K Sell
92
-338
-79% -$57.9K ﹤0.01% 9115
2018
Q4 		$51K Buy
430
+357
+489% +$54.8K ﹤0.01% 8485
2018
Q3 		$11K Sell
73
-76
-51% -$31.8K ﹤0.01% 9109
2018
Q2 		$98K Buy
149
+14
+10% +$10.5K ﹤0.01% 8253
2018
Q1 		$138K Buy
135
+100
+286% +$83.7K ﹤0.01% 7590
2017
Q4 		$42K Sell
35
-26
-43% -$12.2K ﹤0.01% 7680
2017
Q3 		$11K Sell
61
-79
-56% -$12.5K ﹤0.01% 7434
2017
Q2 		$22K Buy
140
+74
+112% +$15K ﹤0.01% 7267
2017
Q1 		$16K Buy
+66
New +$17.7K ﹤0.01% 7308
2016
Q3 		– Sell
-173
Closed -$48.5K – 7949
2016
Q2 		$67K Buy
173
+21
+14% +$22.9K ﹤0.01% 6337
2016
Q1 		$102K Buy
152
+111
+271% +$74.8K ﹤0.01% 6021
2015
Q4 		$43K Buy
+41
New +$40.6K ﹤0.01% 7432
2015
Q3 		– Sell
-248
Closed -$207K – 9352
2015
Q2 		$176K Buy
248
+69
+39% +$73.5K ﹤0.01% 6482
2015
Q1 		$404K Sell
179
-105
-37% -$179K ﹤0.01% 5239
2014
Q4 		$292K Sell
284
-124
-30% -$132K ﹤0.01% 5482
2014
Q3 		$432K Buy
408
+79
+24% +$133K ﹤0.01% 4811
2014
Q2 		$824K Buy
329
+103
+46% +$210K ﹤0.01% 3748
2014
Q1 		$430K Buy
+226
New +$534K ﹤0.01% 4573
2013
Q4 		– Sell
-35
Closed -$82.7K – 7221
2013
Q3 		$79K Buy
+35
New +$67.7K ﹤0.01% 5508

Other funds holding AMPE

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Citadel Advisors's AMPE Position: Q2 2023 in Review

Citadel Advisors sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2023, closing a stake of 382 shares — an estimated $1.78K sold.

Citadel Advisors first reported a position in AMPE in Q3 2013 and held it in 34 quarters. The position peaked at $824K in Q2 2014. 34 funds tracked by Wall St. Rank hold AMPE as of Q2 2023.

  • Citadel Advisors reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • Citadel Advisors sold 382 Ampio Pharmaceuticals Inc. shares in Q2 2023, an estimated $1.78K.
  • Citadel Advisors first reported a position in Ampio Pharmaceuticals Inc. in Q3 2013 and held it in 34 quarters.
  • Citadel Advisors's Ampio Pharmaceuticals Inc. position peaked at $824K in Q2 2014.
  • 34 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.